Correlation Between Reviva Pharmaceuticals and Curative Biotechnology

Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Curative Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Curative Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Curative Biotechnology, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Curative Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Curative Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Curative Biotechnology.

Diversification Opportunities for Reviva Pharmaceuticals and Curative Biotechnology

-0.32

Correlation Coefficient

Reviva Pharmaceuticals  Curative Biotechnology

Very good diversification

The 3 months correlation between Reviva and Curative is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Curative Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curative Biotechnology and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Curative Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curative Biotechnology has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Curative Biotechnology go up and down completely randomly.

Pair Corralation between Reviva Pharmaceuticals and Curative Biotechnology

Assuming the 90 days horizon Reviva Pharmaceuticals Holdings is expected to under-perform the Curative Biotechnology. In addition to that, Reviva Pharmaceuticals is 1.09 times more volatile than Curative Biotechnology. It trades about -0.02 of its total potential returns per unit of risk. Curative Biotechnology is currently generating about 0.08 per unit of volatility. If you would invest  1.39  in Curative Biotechnology on December 22, 2024 and sell it today you would earn a total of  0.14  from holding Curative Biotechnology or generate 10.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Reviva Pharmaceuticals Holding  vs.  Curative Biotechnology

Reviva Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Reviva Pharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Curative Biotechnology

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Curative Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental drivers, Curative Biotechnology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Reviva Pharmaceuticals and Curative Biotechnology

The main advantage of trading using opposite Reviva Pharmaceuticals and Curative Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Curative Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curative Biotechnology will offset losses from the drop in Curative Biotechnology's long position.

The idea behind Reviva Pharmaceuticals Holdings and Curative Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.